X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ASTRAZENECA PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ASTRAZENECA PHARMA ALEMBIC LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 75.7 91.0 83.2% View Chart
P/BV x 2.8 13.0 21.7% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ASTRAZENECA PHARMA
Mar-14
ALEMBIC LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs531,285 4.1%   
Low Rs29634 4.6%   
Sales per share (Unadj.) Rs4.7189.6 2.5%  
Earnings per share (Unadj.) Rs8.8-0.2 -4,309.2%  
Cash flow per share (Unadj.) Rs9.03.8 234.2%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.768.6 40.4%  
Shares outstanding (eoy) m267.0325.00 1,068.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.75.1 171.9%   
Avg P/E ratio x4.7-4,712.7 -0.1%  
P/CF ratio (eoy) x4.6249.6 1.8%  
Price / Book Value ratio x1.514.0 10.6%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,96223,988 45.7%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m2381,605 14.8%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m1,2604,740 26.6%  
Other income Rs m26492 286.4%   
Total revenues Rs m1,5244,832 31.5%   
Gross profit Rs m83-130 -63.8%  
Depreciation Rs m61101 60.7%   
Interest Rs m00-   
Profit before tax Rs m285-139 -205.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32139 -23.2%   
Tax Rs m65 119.8%   
Profit after tax Rs m2,343-5 -46,027.5%  
Gross profit margin %6.6-2.7 -239.9%  
Effective tax rate %2.1-3.7 -58.4%   
Net profit margin %185.9-0.1 -173,099.3%  
BALANCE SHEET DATA
Current assets Rs m1,6892,726 61.9%   
Current liabilities Rs m4862,435 20.0%   
Net working cap to sales %95.46.1 1,552.1%  
Current ratio x3.51.1 310.2%  
Inventory Days Days21774 294.2%  
Debtors Days Days8141 198.8%  
Net fixed assets Rs m1,6241,035 156.9%   
Share capital Rs m53450 1,068.2%   
"Free" reserves Rs m5,960942 632.4%   
Net worth Rs m7,4041,716 431.5%   
Long term debt Rs m1040-   
Total assets Rs m8,0104,156 192.7%  
Interest coverage x950.7NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.21.1 13.8%   
Return on assets %29.3-0.1 -23,883.6%  
Return on equity %31.6-0.3 -10,667.8%  
Return on capital %31.30-  
Exports to sales %2.95.7 51.6%   
Imports to sales %28.96.5 446.5%   
Exports (fob) Rs m37270 13.7%   
Imports (cif) Rs m364306 118.7%   
Fx inflow Rs m37375 9.9%   
Fx outflow Rs m365470 77.6%   
Net fx Rs m-328-96 343.1%   
CASH FLOW
From Operations Rs m346-8 -4,266.7%  
From Investments Rs m-48-146 32.7%  
From Financial Activity Rs m-301862 -34.9%  
Net Cashflow Rs m-3709 -0.4%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 0.3 66.7%  
FIIs % 9.7 15.7 61.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 9.1 286.8%  
Shareholders   54,701 12,856 425.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 22, 2017 01:02 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - VENUS REMEDIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS